\name{find.x}
\alias{find.x}
\title{
Obtain samples from the maximum tolerated dose (MTD) distribution.
}
\description{
Given a posterior (or prior) sample of the parameters, this function inverts the given functional form to obtain samples from the MTD distribution.
}
\usage{
find.x(ff, ptox, alpha)
}
\arguments{
  \item{ff}{
A string indicating the functional form of the dose-response curve. Options are
    \describe{
     \item{ht}{ 1-parameter hyperbolic tangent}
      \item{logit1}{ 1-parameter logistic}
      \item{power}{ 1-parameter power}   
	\item{logit2}{ 2-parameter logistic}
    } 
}
 \item{ptox}{The required probability of DLT. For example, if the MTD distribution is sought then set \code{ptox} to the target toxicity level.}
 \item{alpha}{A sample from the posterior (or prior) distribution of the parameter(s).}
}
\details{
Given a posterior (or prior) sample of the parameters, this function inverts the given functional form to obtain samples from the MTD distribution or any other targeted quantile.
}
\author{
Michael Sweeting \email{mjs212@medschl.cam.ac.uk} (University of Cambridge, UK), drawing on code originally developed by J. Jack Lee and Nan Chen, Department of Biostatistics, the University of Texas M. D. Anderson Cancer Center
}
\references{
 Sweeting M., Mander A., Sabin T. \pkg{bcrm}: Bayesian Continual Reassessment Method Designs for Phase I Dose-Finding Trials. \emph{Journal of Statistical Software} (2013) 54: 1--26. \url{http://www.jstatsoft.org/article/view/v054i13}
}
\seealso{
\code{\link{bcrm}}, \code{\link{getprior}}, \code{\link{Posterior.exact}}, \code{\link{Posterior.BRugs}}, \code{\link{Posterior.R2WinBUGS}}
}
\examples{
## Dose-escalation cancer trial example as described in Neuenschwander et al 2008.
## Pre-defined doses
dose<-c(1,2.5,5,10,15,20,25,30,40,50,75,100,150,200,250)
## Pre-specified probabilities of toxicity
## [dose levels 11-15 not specified in the paper, and are for illustration only]
p.tox0<-c(0.010,0.015,0.020,0.025,0.030,0.040,0.050,0.100,0.170,0.300,0.400,0.500,0.650
  ,0.800,0.900)
## Data from the first 5 cohorts of 18 patients
tox<-c(0,0,0,0,0,0,2,0,0,0,0,0,0,0,0)
notox<-c(3,4,5,4,0,0,0,0,0,0,0,0,0,0,0)
## Target toxicity level
target.tox<-0.30

## Prior distribution for the MTD given a lognormal(0,1.34^2) distribution for alpha
## and a power model functional form
prior.alpha<-list(3,0,1.34^2)
ff<-"power"
samples.alpha<-getprior(prior.alpha,2000)
mtd<-find.x(ff,target.tox,alpha=samples.alpha)
hist(mtd)

## Standardised doses
sdose<-find.x(ff,p.tox0,alpha=1)

## Posterior distribution of the MTD (on standardised dose scale) using data 
## from the cancer trial described in Neuenschwander et al 2008.
## Using rjags
posterior.samples<-Posterior.rjags(tox,notox,sdose,ff,prior.alpha
  ,burnin.itr=2000,production.itr=2000)
posterior.mtd<-find.x(ff,target.tox,alpha=posterior.samples)
hist(posterior.mtd)

}
